PensionDanmark Pensionsforsikringsaktieselskab Has $26.73 Million Position in Intuitive Surgical, Inc. $ISRG

PensionDanmark Pensionsforsikringsaktieselskab increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 15.9% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 67,208 shares of the medical equipment provider’s stock after purchasing an additional 9,212 shares during the period. PensionDanmark Pensionsforsikringsaktieselskab’s holdings in Intuitive Surgical were worth $26,727,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the company. Newbridge Financial Services Group Inc. raised its position in shares of Intuitive Surgical by 300.0% during the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 33 shares during the last quarter. Laurel Wealth Advisors LLC acquired a new position in shares of Intuitive Surgical during the fourth quarter valued at $31,000. Turning Point Benefit Group Inc. boosted its holdings in Intuitive Surgical by 833.3% in the fourth quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider’s stock valued at $32,000 after acquiring an additional 50 shares during the last quarter. Motiv8 Investments LLC acquired a new stake in Intuitive Surgical in the fourth quarter worth about $34,000. Finally, Oakworth Capital Inc. increased its position in Intuitive Surgical by 281.2% in the fourth quarter. Oakworth Capital Inc. now owns 61 shares of the medical equipment provider’s stock worth $35,000 after purchasing an additional 45 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $373.71 on Friday. The firm’s 50 day simple moving average is $393.78 and its 200 day simple moving average is $446.25. Intuitive Surgical, Inc. has a fifty-two week low of $328.57 and a fifty-two week high of $603.88. The company has a market capitalization of $132.02 billion, a price-to-earnings ratio of 42.81, a P/E/G ratio of 2.71 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, beating the consensus estimate of $2.48 by $0.32. The firm had revenue of $2.89 billion during the quarter, compared to the consensus estimate of $2.83 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The business’s quarterly revenue was up 18.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.81 earnings per share. Equities research analysts expect that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current year.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Gary Loeb sold 400 shares of Intuitive Surgical stock in a transaction dated Wednesday, June 10th. The stock was sold at an average price of $424.14, for a total transaction of $169,656.00. Following the transaction, the executive vice president directly owned 5,720 shares in the company, valued at approximately $2,426,080.80. The trade was a 6.54% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Iman Jeddi sold 5,625 shares of the business’s stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $420.55, for a total value of $2,365,593.75. Following the completion of the transaction, the senior vice president directly owned 6,463 shares of the company’s stock, valued at approximately $2,718,014.65. The trade was a 46.53% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 6,634 shares of company stock valued at $2,796,795. 0.60% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on the stock. UBS Group began coverage on shares of Intuitive Surgical in a research report on Tuesday, July 28th. They set a “neutral” rating and a $500.00 target price on the stock. The Goldman Sachs Group set a $558.00 price objective on shares of Intuitive Surgical in a report on Wednesday, May 27th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Intuitive Surgical in a research note on Tuesday, May 19th. BNP Paribas Exane upgraded shares of Intuitive Surgical to an “outperform” rating in a research report on Tuesday, July 28th. Finally, TD Cowen downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Tuesday, July 28th. Twenty equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $509.02.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.